Testing effectiveness (Phase 2)UnknownNCT05073250What this trial is testingIBI376 Plus Rituximab in Patients With Untreated Indolent Lymphoma.Who this might be right forInert Non Hodgkin's Lymphoma Chinese PLA General Hospital 40